The increasing prevalence of type 1 and type 2 diabetes mellitus combined with advancement in early detection of cardiovascular disease (CVD) has placed CVD as a significant concern for preventative pediatric medicine. The public health burden of type 2 diabetes is predicted to parallel increasing obesity in children with a projected increase of early CVD in adulthood. In this article, we review practice guidelines for cardiovascular health in children and adolescents with diabetes and data on which they are based. We then focus on imaging modalities that are promising tools to expand our understanding of the cardiovascular risk imposed on youths with diabetes.
Get full access to this article
View all access options for this article.
References
1.
MeigsJB. Epidemiology of cardiovascular complications in type 2 diabetes mellitus. Acta Diabetol, 2003; 40,Suppl 2:S358–S361.
2.
DonahueRP, OrchardTJ. Diabetes mellitus, macrovascular complications. An epidemiological perspective. Diabetes Care, 1992; 15:1141–1155.
3.
LaingSP, SwerdlowAJ, SlaterSD, BothaJL, BurdenAC, WaughNR, SmithAW, HillRD, BingleyPJ, PattersonCC, QiaoZ, KeenH. The British Diabetic Association Cohort Study. II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med, 1999; 16:466–471.
SolteszG, PattersonCC, DahlquistG. Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology?Pediatr Diabetes, 2007; 8,Suppl 6:6–14.
6.
LieseAD, D'AgostinoRBJr, HammanRF, KilgoPD, LawrenceJM, LiuLL, LootsB, LinderB, MarcovinaS, RodriguezB, StandifordD, WilliamsDE. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics, 2006; 118:1510–1518.
7.
OgdenCL, CarrollMD, CurtinLR, McDowellMA, TabakCJ, FlegalKM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA, 2006; 295:1549–1555.
8.
NadeauKJ, MaahsDM, DanielsSR, EckelRH. Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol, 2011; 8:513–525.
9.
EnosWF, HolmesRH, BeyerJ. Coronary disease among United States soldiers killed in action in Korea; preliminary report. JAMA, 1953; 152:1090–1093.
10.
NewmanWP3rd, FreedmanDS, VoorsAW, GardPD, SrinivasanSR, CresantaJL, WilliamsonGD, WebberLS, BerensonGS. Relation of serum lipoprotein levels, systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med, 1986; 314:138–144.
11.
StrongJP, MalcomGT, McMahanCA, TracyRE, NewmanWP3rd, HerderickEE, CornhillJF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA, 1999; 281:727–735.
12.
TardifJC, HeinonenT, OrloffD, LibbyP. Vascular biomarkers and surrogates in cardiovascular disease. Circulation, 2006; 113:2936–2942.
13.
FlemingTR, DeMetsDL. Surrogate end points in clinical trials: are we being misled?Ann Intern Med, 1996; 125:605–613.
14.
GoldsteinJL, HazzardWR, SchrottHG, BiermanEL, MotulskyAG. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest, 1973; 52:1533–1543.
15.
CastelliWP, GarrisonRJ, WilsonPW, AbbottRD, KalousdianS, KannelWB. Incidence of coronary heart disease, lipoprotein cholesterol levels. The Framingham study. JAMA, 1986; 256:2835–2838.
16.
KrolewskiAS, KosinskiEJ, WarramJH, LelandOS, BusickEJ, AsmalAC, RandLI, ChristliebAR, BradleyRF, KahnCR. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol, 1987; 59:750–755.
17.
LaingSP, SwerdlowAJ, SlaterSD, BurdenAC, MorrisA, WaughNR, GatlingW, BingleyPJ, PattersonCC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, 2003; 46:760–765.
OrchardTJ. From diagnosis, classification to complications, therapy. DCCT. Part II? Diabetes Control and Complications Trial. Diabetes Care, 1994; 17:326–338.
20.
NathanDM, ClearyPA, BacklundJY, GenuthSM, LachinJM, OrchardTJ, RaskinP, ZinmanB. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005; 353:2643–2653.
21.
PrinceCT, BeckerDJ, CostacouT, MillerRG, OrchardTJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC)Diabetologia, 2007; 50:2280–2288.
22.
MustA, JacquesPF, DallalGE, BajemaCJ, DietzWH. Long-term morbidity, mortality of overweight adolescents. A follow-up of the harvard growth study of 1922 to 1935. N Engl J Med, 1992; 327:1350–1355.
23.
LibbyP, PlutzkyJ. Diabetic macrovascular disease: the glucose paradox?Circulation, 2002; 106:2760–2763.
24.
GuyJ, OgdenL, WadwaRP, HammanRF, Mayer-DavisEJ, LieseAD, D'AgostinoRJr, MarcovinaS, DabeleaD. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: The SEARCH for Diabetes in Youth case-control study. Diabetes Care, 2009; 32:416–420
25.
OrchardTJ, CostacouT. When are type 1 diabetic patients at risk for cardiovascular disease?Curr Diabetes Rep, 2010; 10:48–54.
26.
EbaraT, CondeK, KakoY, LiuY, XuY, RamakrishnanR, GoldbergIJ, ShachterNS. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J Clin Invest, 2000; 105:1807–1818.
27.
SchauerIE, Snell-BergeonJK, BergmanBC, MaahsDM, KretowskiA, EckelRH, RewersM. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes, 2011; 60:306–314.
28.
NadeauKJ, ReuschJE. Cardiovascular function/dysfunction in adolescents with type 1 diabetes. Curr Diabetes Rep, 2011; 11:185–192.
29.
HassounaA, LoubaniM, MatataBM, FowlerA, StandenNB, GalinanesM. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res, 2006; 69:450–458.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005; 54:1615–1625.
32.
American Diabetes Association:. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care, 2003; 26:2194–2197.
33.
BetteridgeDJ. Diabetic dyslipidemia. Am J Med, 1994; 96:25S–31S.
34.
SiegelRD, CupplesA, SchaeferEJ, WilsonPW. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham Offspring Study. Metabolism, 1996; 45:1267–1272.
35.
BerensonGS, SrinivasanSR, BaoW, NewmanWP3rd, TracyRE, WattigneyWA. Association between multiple cardiovascular risk factors, atherosclerosis in children, young adults. The Bogalusa Heart Study. N Engl J Med, 1998; 338:1650–1656.
36.
LauerRM, ClarkeWR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study. JAMA, 1990; 264:3034–3038.
37.
OrchardTJ, ForrestKY, KullerLH, BeckerDJ. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care, 2001; 24:1053–1059.
38.
RosenbloomAL, SilversteinJH, AmemiyaS, ZeitlerP, KlingensmithGJ. Type 2 diabetes in children and adolescents. Pediatr Diabetes, 2009; 10,Suppl 12:17–32.
39.
KaveyRE, AlladaV, DanielsSR, HaymanLL, McCrindleBW, NewburgerJW, ParekhRS, SteinbergerJ. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation, 2006; 114:2710–2738.
40.
ReynoldsK, LieseAD, AndersonAM, DabeleaD, StandifordD, DanielsSR, WaitzfelderB, CaseD, LootsB, ImperatoreG, LawrenceJM. Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr, 2011; 158:594–601.
41.
American Diabetes Association:. Standards of medical care in diabetes—2010. Diabetes Care, 2010; 33,Suppl 1:S11–S61.
42.
McCrindleBW, UrbinaEM, DennisonBA, JacobsonMS, SteinbergerJ, RocchiniAP, HaymanLL, DanielsSR. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation, 2007; 115:1948–1967.
43.
KendallDM. Blood pressure targets in diabetes: is this the time for change?J Clin Hypertens (Greenwich), 2011; 13:258–262.
44.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Summary report. Pediatrics, 2011; 128,Suppl 5:S213–S256.
45.
GenuthS, Ismail-BeigiF. Clinical implications of the ACCORD trial. J Clin Endocrinol Metab, 2012; 97:41–48.
46.
HametP. What matters in ADVANCE and ADVANCE-ON. Diabetes Obes Metab, 2012; 14,Suppl 1:20–29.
47.
NathanDM, LachinJ, ClearyP, OrchardT, BrillonDJ, BacklundJY, O'LearyDH, GenuthS. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003; 348:2294–2303.
48.
ClearyPA, OrchardTJ, GenuthS, WongND, DetranoR, BacklundJY, ZinmanB, JacobsonA, SunW, LachinJM, NathanDM. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes, 2006; 55:3556–3565.
49.
ZarichSW, ArbuckleBE, CohenLR, RobertsM, NestoRW. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol, 1988; 12:114–120.
50.
ZhangX, ChenC. A new insight of mechanisms, diagnosis, treatment of diabetic cardiomyopathy. Endocrine, 2012Feb12[Epub ahead of print]10.1007/s12020-012-9623-1.
51.
CeGV, RohdeLE, da SilvaAM, PunalesMK, de CastroAC, BertoluciMC. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J Clin Endocrinol Metab, 2011; 96:1493–1499.
52.
BeckmanJA, CreagerMA, LibbyP. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 2002; 287:2570–2581.
53.
GianniniC, MohnA, ChiarelliF, KelnarCJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev, 2011; 27:436–460.
54.
NadeauKJ, ZeitlerPS, BauerTA, BrownMS, DoroszJL, DrazninB, ReuschJE, RegensteinerJG. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab, 2009; 94:3687–3695.
55.
NadeauKJ, RegensteinerJG, BauerTA, BrownMS, DoroszJL, HullA, ZeitlerP, DrazninB, ReuschJE. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab, 2010; 95:513–521.
56.
WangL, Jerosch-HeroldM, JacobsDRJr., ShaharE, DetranoR, FolsomAR. Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis)J Am Coll Cardiol, 2006; 48:1018–1026.
57.
UrbinaEM, WilliamsRV, AlpertBS, CollinsRT, DanielsSR, HaymanL, JacobsonM, MahoneyL, Mietus-SnyderM, RocchiniA, SteinbergerJ, McCrindleB. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension, 2009; 54:919–950.
UrbinaEM, WadwaRP, DavisC, SnivelyBM, DolanLM, DanielsSR, HammanRF, DabeleaD. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site, sex: The SEARCH for Diabetes in Youth Study. J Pediatr, 2010; 156:731–737737.e1.
60.
HallerMJ, SamynM, NicholsWW, BruskoT, WasserfallC, SchwartzRF, AtkinsonM, ShusterJJ, PierceGL, SilversteinJH. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care, 2004; 27:2911–2917.
61.
BrooksB, MolyneauxL, YueDK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care, 1999; 22:1722–1727.
62.
BrooksBA, MolyneauxLM, YueDK. Augmentation of central arterial pressure in type 2 diabetes. Diabet Med, 2001; 18:374–380.
63.
O'LearyDH, PolakJF, KronmalRA, ManolioTA, BurkeGL, WolfsonSKJr. Carotid-artery intima, media thickness as a risk factor for myocardial infarction, stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999; 340:14–22.
64.
AzenSP, MackWJ, Cashin-HemphillL, LaBreeL, ShircoreAM, SelzerRH, BlankenhornDH, HodisHN. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation, 1996; 93:34–41.
65.
ChamblessLE, HeissG, FolsomAR, RosamondW, SzkloM, SharrettAR, CleggLX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol, 1997; 146:483–494.
66.
SinghTP, GroehnH, KazmersA. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol, 2003; 41:661–665.
67.
JarvisaloMJ, RaitakariM, ToikkaJO, Putto-LaurilaA, RontuR, LaineS, LehtimakiT, RonnemaaT, ViikariJ, RaitakariOT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation, 2004; 109:1750–1755.
68.
MargolisJR, ChenJT, KongY, PeterRH, BeharVS, KissloJA. The diagnostic, prognostic significance of coronary artery calcification. A report of 800 cases. Radiology, 1980; 137:609–616.
69.
DabeleaD, KinneyG, Snell-BergeonJK, HokansonJE, EckelRH, EhrlichJ, GargS, HammanRF, RewersM. Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes, 2003; 52:2833–2839.
70.
StarkmanHS, CableG, HalaV, HechtH, DonnellyCM. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care, 2003; 26:433–436.
71.
GodslandIF, PavittD, OkoturoO, EdwardsRJ, RubensMB, FeherMD, FlatherMD, ElkelesRS. Can protein biomarkers provide an index of coronary artery calcification in patients with type 2 diabetes?Atherosclerosis, 2010; 213:570–572.
72.
Di BelloV, TalaricoL, PicanoE, Di MuroC, LandiniL, PaterniM, MatteucciE, GiustiC, GiampietroO. Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol, 1995; 25:1408–1415.
73.
FraserGE, LukeR, ThompsonS, SmithH, CarterS, SharpeN. Comparison of echocardiographic variables between type I diabetics and normal controls. Am J Cardiol, 1995; 75:141–145.
74.
SalemM, El BeheryS, AdlyA, KhalilD, El HadidiE. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes, 2009; 10:513–521.
75.
NaguehSF, MiddletonKJ, KopelenHA, ZoghbiWA, QuinonesMA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol, 1997; 30:1527–1533.
76.
VazeouA, PapadopoulouA, MihaM, DrakatosA, GeorgacopoulosD. Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM)Eur J Pediatr, 2008; 167:877–884.
77.
KaravanakiK, KazianisG, KonstantopoulosI, TsouvalasE, KarayianniC. Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate. J Endocrinol Invest, 2008; 31:289–296.
78.
MehtaSK, HollidayC, HaydukL, WiersmaL, RichardsN, YounoszaiA. Comparison of myocardial function in children with body mass indexes ≥25 versus those <25 kg/m2. Am J Cardiol, 2004; 93:1567–1569.
79.
Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics, 2000; 105:671–680.
80.
MizushigeK, YaoL, NomaT, KiyomotoH, YuY, HosomiN, OhmoriK, MatsuoH. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation, 2000; 101:899–907.
81.
KimEH, KimYH. Left ventricular function in children and adolescents with type 1 diabetes mellitus. Korean Circ J, 2010; 40:125–130.
82.
LarsenJR, TsunodaT, TuzcuEM, SchoenhagenP, BrekkeM, ArnesenH, HanssenKF, NissenSE, Dahl-JorgensenK. Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls. Diabetes Vasc Dis Res, 2007; 4:62–65.
83.
TurkbeyEB, BacklundJY, GenuthS, JainA, MiaoC, ClearyPA, LachinJM, NathanDM, van der GeestRJ, SolimanEZ, LiuCY, LimaJA, BluemkeDA. Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation, 2011; 124:1737–1746.
84.
EspositoL, SaamT, HeiderP, BockelbrinkA, PelisekJ, SeppD, FeurerR, WinklerC, LiebigT, HolzerK, PaulyO, SadikovicS, HemmerB, PoppertH. MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis. BMC Med Imaging, 2010; 10:27.
